Blog

by Amy DuRoss | June 16, 2020
We’ve launched the new Vineti Alliance Network to deliver an enterprise-grade approach to integrated solutions for clinical and commercial advanced therapy manufacturers. As a key part of this new network, we’ve also announced a collaboration with…

by Vineti | May 20, 2020
Cardinal Health and Vineti Inc. announced a collaboration to support cell and gene therapy manufacturers with a fully integrated solution that aligns logistics and commercialization services with digital Chain of Identity and Chain of Custody…

by Heidi Hagen and Subbu Viswanathan | March 18, 2020
This post is the final post in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management) for personalized therapies, such as cell therapies, gene therapies, or neoantigen cancer vaccines. This series focuses…

by Heidi Hagen and Subbu Viswanathan | March 11, 2020
This post is the fourth in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management) for personalized therapies, such as cell therapies, gene therapies, or neoantigen cancer vaccines. This series focuses…

by Heidi Hagen and Subbu Viswanathan | March 3, 2020
This post is the third in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management) for personalized therapies, such as cell therapies, gene therapies, or neoantigen cancer vaccines. This series focuses…

Subscribe to our blog
Required
Required
Required
Required
Required
Required
Required